Aimovig Market Report 2026
Download Free Sample Buy Now
Aimovig Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Aimovig Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Aimovig Market Overview

• The Aimovig market growth in the historic period has been driven by high migraine prevalence, limited effectiveness of traditional therapies

• Market expansion is supported by growth in chronic migraine diagnosis, expansion of insurance coverage

• Growth Driver: Rising Migraine Incidence Fuels Growth Of Aimovig Market

• North America was the largest region in 2025.

What Is Covered Under Aimovig Market?

Aimovig is a therapy designed to prevent migraines by targeting the calcitonin gene-related peptide (CGRP) receptor. It works by blocking CGRP activity, a protein that contributes to the occurrence of migraines, thereby reducing their frequency and severity.

The main clinical indication for aimovig is migraine, cluster headache, other headache disorders. A migraine is a type of primary headache disorder characterized by recurrent, often severe, headaches that are typically one-sided (though they can affect both sides), and are often accompanied by other symptoms such as nausea, vomiting, and sensitivity to light, sound, or smells. These are distributed through various distribution channels such as hospital and clinics, retail and specialty pharmacies and are used by various end users such as adult, geriatric.

Aimovig Market Global Report 2026 Market Report bar graph

What Is The Aimovig Market Size and Share 2026?

The growth in the historic period can be attributed to high migraine prevalence, limited effectiveness of traditional therapies, approval of cgrp inhibitors, neurologist adoption, patient demand for preventive options.

What Is The Aimovig Market Growth Forecast?

The growth in the forecast period can be attributed to growth in chronic migraine diagnosis, expansion of insurance coverage, increased biologic drug acceptance, improved patient outcomes data, rising neurology specialist visits. Major trends in the forecast period include growing adoption of cgrp targeted therapies, rising focus on preventive migraine treatment, shift from acute to long term migraine management, increased use of biologic therapies, expansion of specialty pharmacy distribution.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Aimovig Market Segmentation

1) By Clinical Indication: Migraine, Cluster Headache, Other Headache Disorders

2) By Distribution Channel: Hospital And Clinics, Retail And Specialty Pharmacies

3) By End User: Adult, Geriatric

What Are The Drivers Of The Aimovig Market?

The increasing incidence of migraine disorders is expected to propel the growth of the aimovig market going forward. Migraine, a complex neurological condition, is characterized by recurring headaches often accompanied by nausea, sensitivity to light and sound, and other symptoms. The rising incidence is due to several factors, including lifestyle changes, increasing stress levels, genetic predispositions, hormonal fluctuations (particularly in women), and greater diagnostic awareness. Aimovig, the first FDA-approved CGRP receptor blocker, is a leading treatment that addresses the unmet needs of migraine patients by offering a targeted, preventive solution. Aivimog is an innovative migraine management platform that uses advanced AI-driven algorithms to track, analyze, and predict migraine triggers, providing personalized recommendations for prevention, symptom relief, and real-time management through data-driven insights, ultimately helping migraine patients reduce the frequency, intensity, and duration of their attacks while improving their overall quality of life. For instance, in March 2024, according to the House of Commons Library, a UK-based government agency, approximately 10 million people live with migraine in the UK. Therefore, the increasing incidence of migraine disorders drives the aimovig industry.

The rise in healthcare spending is expected to propel the growth of the aimovig market going forward. Healthcare spending refers to the total financial resources allocated by individuals, governments, private insurers, and other entities towards the provision of healthcare services and products. The rise in healthcare spending is attributed to aging population, advancements in medical technology, rising prevalence of chronic diseases, and increased demand for healthcare services. Healthcare spending supports Aimovig by driving investment in innovative treatments, expanding patient access through insurance coverage, funding ongoing research and development for improved therapeutic outcomes, and promoting public health initiatives that raise awareness and enhance the overall adoption of migraine prevention therapies. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, between 2022 and 2023, healthcare spending in the UK increased by 5.6% compared with growth of 0.9% in 2022. The UK healthcare expenditure in UK healthcare expenditure was around $317.63 billion (£292 billion) in 2023. Therefore, rise in healthcare spending is driving the growth of the aimovig industry.

Rising personalized medicine is expected to propel the growth of the aimovig market going forward. Personalized medicine is a medical approach that tailors treatment and healthcare strategies to the individual characteristics of each patient, such as their genetic makeup, environment, and lifestyle, to achieve the most effective and precise outcomes. The rising personalized medicine is due to advancements in genomic technologies, increased understanding of molecular biology, growing availability of precision diagnostic tools, and the demand for targeted therapies that improve patient outcomes while minimizing side effects. Aimovig, a monoclonal antibody designed to target and block the calcitonin gene-related peptide receptor, helps personalize medicine by providing an effective, tailored treatment for individuals suffering from chronic migraines, enabling healthcare providers to select the most appropriate therapy based on patient-specific factors, such as treatment history, efficacy, and tolerability, ultimately optimizing outcomes for each patient. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, a significant increase from the six approved in 2022. Therefore, rising personalized medicine drives the aimovig industry.

Key Players In The Global Aimovig Market

Major companies operating in the aimovig market are Novartis AG, Amgen Inc.

Need data on a specific region in this market?
Request Regional Data

Regional Insights

North America was the largest region in the aimovig market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Aimovig Market?

The aimovig market consists of sales of monoclonal antibody-based therapies specifically developed to prevent migraines by inhibiting CGRP receptor activity. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Aimovig Market Report 2026?

The aimovig market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the aimovig industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Aimovig Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Clinical Indication, Distribution Channel, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Novartis AG, Amgen Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Aimovig Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Aimovig Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Aimovig Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Aimovig Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Growing Adoption Of CGRP Targeted Therapies

4.2.2 Rising Focus On Preventive Migraine Treatment

4.2.3 Shift From Acute To Long Term Migraine Management

4.2.4 Increased Use Of Biologic Therapies

4.2.5 Expansion Of Specialty Pharmacy Distribution

5. Aimovig Market Analysis Of End Use Industries

5.1 Adult Patients

5.2 Geriatric Patients

5.3 Neurology Clinics

5.4 Hospitals

5.5 Specialty Pharmacies

6. Aimovig Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Aimovig Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Aimovig PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Aimovig Market Size, Comparisons And Growth Rate Analysis

7.3. Global Aimovig Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Aimovig Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Aimovig Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Aimovig Market Segmentation

9.1. Global Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Migraine, Cluster Headache, Other Headache Disorders

9.2. Global Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital And Clinics, Retail And Specialty Pharmacies

9.3. Global Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult, Geriatric

10. Aimovig Market Regional And Country Analysis

10.1. Global Aimovig Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Aimovig Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Aimovig Market

11.1. Asia-Pacific Aimovig Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Aimovig Market

12.1. China Aimovig Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Aimovig Market

13.1. India Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Aimovig Market

14.1. Japan Aimovig Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Aimovig Market

15.1. Australia Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Aimovig Market

16.1. South Korea Aimovig Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Aimovig Market

17.1. Western Europe Aimovig Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Aimovig Market

18.1. UK Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Aimovig Market

19.1. Germany Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Aimovig Market

20.1. France Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Aimovig Market

21.1. Eastern Europe Aimovig Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Aimovig Market

22.1. North America Aimovig Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Aimovig Market

23.1. USA Aimovig Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Aimovig Market

24.1. Canada Aimovig Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Aimovig Market

25.1. South America Aimovig Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Aimovig Market

26.1. Middle East Aimovig Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Aimovig Market

27.1. Africa Aimovig Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Aimovig Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Aimovig Market Regulatory and Investment Landscape

29. Aimovig Market Competitive Landscape And Company Profiles

29.1. Aimovig Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Aimovig Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Aimovig Market Company Profiles

29.3.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

29.3.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Aimovig Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Aimovig Market

32. Aimovig Market High Potential Countries, Segments and Strategies

32.1 Aimovig Market In 2030 - Countries Offering Most New Opportunities

32.2 Aimovig Market In 2030 - Segments Offering Most New Opportunities

32.3 Aimovig Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Aimovig Market, Overview Of Key Products - Product Examples
  • Table 2: Global Aimovig Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Aimovig Market, Supply Chain Analysis
  • Table 4: Global Aimovig Market, Major Raw Material Providers
  • Table 5: Global Aimovig Market, Major Resource Providers
  • Table 6: Global Aimovig Market, Major Manufacturers (Suppliers)
  • Table 7: Global Aimovig Market, Major Distributors And Channel Partners
  • Table 8: Global Aimovig Market, Key Technologies & Future Trends
  • Table 9: Global Aimovig Market, Major Trends
  • Table 10: Global Aimovig Market, Major End Users
  • Table 11: Global Aimovig Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Aimovig Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Aimovig Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Aimovig Market - TAM, US$ Billion, 2025
  • Table 15: Global Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Aimovig Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Aimovig Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Asia-Pacific, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: China, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: India, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Japan, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Australia, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: South Korea, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Western Europe, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: UK, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Germany, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: France, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Eastern Europe, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: North America, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: USA, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Canada, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: South America, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Middle East, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Africa, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Global Aimovig Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 72: Global Aimovig Market - Company Scoring Matrix
  • Table 73: Novartis AG Financial Performance
  • Table 74: Amgen Inc. Financial Performance
  • Table 75: Global Aimovig Market, Competitive Benchmarking (In USD Billions)
  • Table 76: Global Aimovig Market, Competitive Dashboard
  • Table 77: Global Aimovig Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 78: Global, Aimovig Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030
  • Table 79: Global, Aimovig Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
  • Table 80: Global, Aimovig Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Aimovig Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Aimovig Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Aimovig Market, Supply Chain Analysis
  • Figure 4: Global Aimovig Market, Major Raw Material Providers
  • Figure 5: Global Aimovig Market, Major Resource Providers
  • Figure 6: Global Aimovig Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Aimovig Market, Major Distributors And Channel Partners
  • Figure 8: Global Aimovig Market, Key Technologies & Future Trends
  • Figure 9: Global Aimovig Market, Major Trends
  • Figure 10: Global Aimovig Market, Major End Users
  • Figure 11: Global Aimovig Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Aimovig Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Aimovig Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Aimovig Market - TAM, US$ Billion, 2025
  • Figure 15: Global Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Aimovig Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Aimovig Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Asia-Pacific, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: China, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: India, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Japan, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Australia, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: South Korea, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Western Europe, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: UK, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Germany, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: France, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Eastern Europe, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: North America, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: USA, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Canada, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: South America, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Middle East, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Africa, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Aimovig Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Global Aimovig Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 72: Global Aimovig Market - Company Scoring Matrix
  • Figure 73: Novartis AG Financial Performance
  • Figure 74: Amgen Inc. Financial Performance
  • Figure 75: Global Aimovig Market, Competitive Benchmarking (In USD Billions)
  • Figure 76: Global Aimovig Market, Competitive Dashboard
  • Figure 77: Global Aimovig Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 78: Global, Aimovig Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030
  • Figure 79: Global, Aimovig Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
  • Figure 80: Global, Aimovig Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Data Lake Market Report 2026 - Global Outlook – By Type (Solution, Services), By Deployment (On-Premise, Cloud), By Organization Size (Large Enterprises, Small And Medium-Sized Enterprises (SMEs)), By Vertical (Informati...

Vertical Market Software Market Report 2026 - Global Outlook – By Software Type (Banking Software, Education Software, Legal Software, Agriculture Software, Alumni Management Software, Amusement Park Software, Apparel So...

Investments Market Report 2026 - Global Outlook – By Type (Wealth Management, Securities Brokerage And Stock Exchange Services, Investment Banking), By Mode (Online, Offline), By End User (B2B, B2C) – Market Size, Trends...

Trade Finance Market Report 2026 - Global Outlook – By Type (Supply Chain Finance, Structured Trade Finance, Traditional Trade Finance), By Service Provider (Banks, Financial Institutions, Trading Houses, Other Services)...

Impact Investing Market Report 2026 - Global Outlook – By Illustrative Sector (Education, HealthCare, Housing, Agriculture, Environment, Clean Energy Access, Climate Change, Other Illustrative Sectors), By Investment Ins...

Industrial Analytics Market Report 2026 - Global Outlook – By Analytics Type (Predictive Analytics, Prescriptive Analytics, Descriptive Analytics, Diagnostic Analytics), By Organization Size (Large Organizations, Small A...

Market Research Services Market Report 2026 - Global Outlook – By Type (Marketing Research And Analysis Services, Public Opinion And Election Polling), By Research Methodology (Qualitative Research, Quantitative Research...

Financial Analytics Market Report 2026 - Global Outlook – By Component (Solution, Services), By Deployment Mode (On-Premise, Cloud), By Organization Size (Large Enterprises, Small And Medium Sized Enterprises), By Applic...

Frequently Asked Questions

The Aimovig market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Aimovig market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Aimovig market Include, Novartis AG, Amgen Inc. .

Major trend in this market includes: nan. For further insights on this market. request a sample here

North America was the largest region in the aimovig market in 2025. The regions covered in the aimovig market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us